InsidersTradesSigma
Track the 苑东生物 share price and the full management transaction log of the company, a listed equity based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 苑东生物 has recorded 1 reports. Market capitalisation: €8.6bn. The latest transaction was filed on 28 July 2025 (Sale). Among the most active insiders: 成都楠苑投资合伙企业(有限合伙). All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
苑东生物 是一家在上海证券交易所上市的健康和制药领域的公司。该公司专注于创新药物的研发。